explore -WSS

explore

author：entertainment 2025-08-28 13:04:08 - browse：7

The FDA building -- First Opinion coverage from STAT — Adobe

The Food and Drug Administration said Monday that it has deep reservations about NurOwn, an investigational ALS treatment from BrainStorm Cell Therapeutics, citing a lack of evidence that the medicine works and the company’s failure to demonstrate that it can properly manufacture the product.

In documents disclosed ahead of a Wednesday public hearing on NurOwn’s application for approval, the FDA detailed its problems with a clinical trial that missed its primary objective and noted that BrainStorm submitted “grossly deficient” information on how the medicine is made, voicing “major concerns that the available data do not meet the statutory standard of substantial evidence of effectiveness to support” approval.

BrainStorm filed for approval over the FDA’s protest, insisting that NurOwn has demonstrated benefits for a subset of ALS patients with milder disease. That conclusion, based on an after-the-fact analysis of the company’s failed pivotal trial, has proved polarizing among patients and physicians, with some arguing that the FDA should exercise flexibility in light of the irrevocably fatal nature of ALS and others demanding BrainStorm conduct another clinical trial to demonstrate its benefits.

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： Medicare details structure of new drug price negotiation program
Next article： Woman gored by Bison at Yellowstone

Wikipedia

WSS

At Orexo, a ‘turning point’ for everything but digital health

Doctors find melanoma drugs effective against rare brain cancer

Why hospitals are withdrawing from US News rankings

Cosmetics set for new safety regulation. Why the industry is on board

Care demand spikes challenge UnitedHealth’s provider arm

STAT Virtual Event: The State of Biosimilars: What to Watch

explore

explore

focus

Malaria cases in Florida and Texas: Here’s what you need to know

Rescued Australian man who was adrift 3 months in Pacific with dog 'grateful' to be alive

Medical records are filled with copy

Group opposing PBM reform sets lobbying record

What does generative AI mean for health care? We asked experts

Key House panel plots a new health care package

Virginia high school admissions case could be legal follow

Woman gored by Bison at Yellowstone

Malaria cases in Florida and Texas: Here’s what you need to know

AI can’t replace a physician’s gut feeling

leisure time

A public scorecard can help hold safety

Whistleblower: Blue Cross Blue Shield evaded $170 million in taxes

How Medicaid coverage policies for immigrants impact new moms

Medicare has a new plan to address drug shortages

Biden tests positive for Covid

STAT Virtual Event: The State of Biosimilars: What to Watch

focus

hotspot

Wikipedia

hotspot